Naloxegol for Opioid-Induced Constipation: Mechanism of Action and Clinical Implications

被引:0
|
作者
Tack, Jan F.
Cimen, Ali
Khanh Bui
Sostek, Mark
机构
关键词
D O I
10.1016/S0016-5085(16)31850-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1597
引用
收藏
页码:S538 / S538
页数:1
相关论文
共 50 条
  • [1] Clinical utility of naloxegol in the treatment of opioid-induced constipation
    Bruner, Heather C.
    Atayee, Rabia S.
    Edmonds, Kyle P.
    Buckholz, Gary T.
    JOURNAL OF PAIN RESEARCH, 2015, 8 : 289 - 294
  • [2] Naloxegol for managing opioid-induced constipation
    Shelton, Krystal N.
    Clements, Jennifer N.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2017, 30 (09): : 51 - 53
  • [4] Naloxegol (Movantik) for Opioid-Induced Constipation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1478): : 135 - 137
  • [5] Naloxegol for the treatment of opioid-induced constipation
    Tack, Jan
    Corsetti, Maura
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (08) : 855 - 861
  • [7] Evaluating naloxegol for the treatment of opioid-induced constipation
    Daniali, Marzieh
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (08) : 883 - 891
  • [9] Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK
    Lawson, Richard
    Ryan, James
    King, Frederic
    Goh, Jo Wern
    Tichy, Eszter
    Marsh, Kevin
    PHARMACOECONOMICS, 2017, 35 (02) : 225 - 235
  • [10] Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
    Chey, William D.
    Webster, Lynn
    Sostek, Mark
    Lappalainen, Jaakko
    Barker, Peter N.
    Tack, Jan
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (25): : 2387 - 2396